Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use.
Peter Shane HamblinRosemary WongElif Ilhan EkinciSashikala RagunathanShananthan BalachandranAviva FrydmanTimothy P HanrahanRaymond T HuShara N KetAlan MossMark NgSashikala RagunathanLeon A BachPublished in: Clinical endocrinology (2021)
In SGLT2i-treated diabetes, lower BMI was a novel risk factor for higher ketones precolonoscopy. Pending larger confirmatory studies, extra vigilance for ketoacidosis is warranted in these people.